1 From the Department of Radiology, Hospital Sírio-Libanês, Rua Dona Adma Jafet 91, Bela Vista, São Paulo, SP 01308-050, Brazil (D.N.D.S., N.H., M.M., G.V.F., K.S., M.Q., P.V.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (N.H.); and Joint Department of Medical Imaging, University Health Network-Mount Sinai Hospital-Women's College Hospital, University of Toronto, Toronto, Ontario, Canada (A.B.D., S.G.).
Conventional as well as advanced imaging modalities contribute to accurate detection of prostate cancer and have important roles in screening, staging, active surveillance, and evaluation for biochemical recurrence.